Breaking News Instant updates and real-time market news.

TBPH

Theravance Biopharma

$24.00

-1.21 (-4.80%)

, CPIX

Cumberland

$5.29

-0.13 (-2.40%)

08:36
11/06/18
11/06
08:36
11/06/18
08:36

Theravance Biopharma announces sale of Vibativ to Cumberland Pharmaceuticals

Theravance Biopharma (TBPH) announced the sale of its proprietary antibiotic, Vibativ, to Cumberland Pharmaceuticals (CPIX), a specialty pharmaceutical company focused on the delivery of high-quality prescription brands to improve patient care. Under the terms of the agreement, Cumberland will pay Theravance Biopharma a total of $25M and tiered royalties of up to 20% on future U.S. net product sales. The transaction is expected to close in mid-November, pending satisfaction of customary closing conditions. Theravance Biopharma will provide additional remarks on its previously-scheduled third quarter 2018 earnings call. "This transaction with Cumberland Pharmaceuticals allows Theravance Biopharma to sharpen our focus on our most important strategic priorities, including preparations for the potential launch of YUPELRI in COPD, if approved, plus executing on key pipeline programs. VIBATIV plays an important role in the growing global battle against antibiotic resistance. As we continue our focus on important programs outside of the anti-infectives market, we determined that the product could be best supported by another party. We believe that Cumberland's track record of successfully marketing and selling hospital-based products combined with VIBATIV's existing base of hospital formulary inclusions positions them to drive commercial success for VIBATIV as a flagship product and ensures the important therapeutic benefits of VIBATIV reach as many patients as possible," stated Rick Winningham, chairman and CEO at Theravance.

TBPH

Theravance Biopharma

$24.00

-1.21 (-4.80%)

CPIX

Cumberland

$5.29

-0.13 (-2.40%)

  • 06

    Nov

  • 12

    Nov

  • 13

    Nov

  • 27

    Nov

  • 12

    Dec

TBPH Theravance Biopharma
$24.00

-1.21 (-4.80%)

05/09/18
LEER
05/09/18
NO CHANGE
Target $31
LEER
Outperform
Theravance Biopharma price target lowered to $31 from $41 at Leerink
Leerink analyst Geoffrey Porges lowered his price target for Theravance Biopharma to $31 from $41 after the company reported Q1 operational results and announced the discontinuation of its independent development of velusetrag in gastroparesis based on feedback from the FDA about the requirement for large phase III safety and efficacy study as a requirement for approval. The analyst reiterates an Outperform rating on the shares.
08/01/18
PIPR
08/01/18
NO CHANGE
Target $55
PIPR
Overweight
Theravance Biopharma price target raised to $55 from $45 at Piper Jaffray
Piper Jaffray analyst Tyler Van Buren raised his price target for Theravance Biopharma (TBPH) to $55 saying the proof of concept demonstrated for TD-9855 in neurogenic orthostatic hypotension compare favorably to Lundbeck's Northera. Considering Northera is run-rating at $250M-$300M about four years post launch with minimal patient penetration of the target population, a differentiated TD-9855 could ultimately achieve $500M-plus in peak sales, Van Buren tells investors in a research note. Further, the analyst believes an accelerated approval could be possible. He reiterates an Overweight rating on Theravance Biopharma.
09/27/18
PIPR
09/27/18
NO CHANGE
Target $55
PIPR
Overweight
Theravance financial flexibility, assets underappreciated, says Piper Jaffray
Piper Jaffray analyst Tyler Van Buren says recent meetings with Theravance Biopharma management support his Overweight rating on the shares. The Trelegy royalty stream could potentially be monetized in the near-term as a source of non-dilutive financing, which would alleviate concerns regarding the need for cash, a significant portion of the current bear thesis, Van Buren tells investors in a research note. Further, he notes that management remains confident in a Yupelri approval on November 13. The analyst continues to recommend that investors own Theravance shares as he believes both its financial flexibility and current assets are underappreciated.
10/23/18
PIPR
10/23/18
NO CHANGE
PIPR
Overweight
Piper says Theravance data shows 'disruptive potential' of oral JAK inhibitor
After Theravance Biopharma (TBPH) presented four-week data from the Phase Ib ulcerative colitis study of TD-1473, a gut-selective pan-JAK inhibitor for the treatment of inflammatory bowel disease, at the United European Gastroenterology Week, Piper Jaffray analyst Tyler Van Buren said the data provides substantial proof of concept and shows the "disruptive potential" that could lead to "multi-billion" global sales for Theravance and partner Janssen (JNJ). He maintains an Overweight rating on Theravance shares.
CPIX Cumberland
$5.29

-0.13 (-2.40%)

04/17/18
RILY
04/17/18
INITIATION
Target $9.25
RILY
Buy
Cumberland initiated with a Buy at B. Riley FBR
B. Riley FBR analyst Andrew D'Silva started Cumberland Pharmaceuticals with a Buy rating and $9.25 price target. The company's base business "more than justifies" the current valuation while its pipeline offers "game-changing" potential, D'Silva tells investors in a research note.

TODAY'S FREE FLY STORIES

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

16:17
02/22/19
02/22
16:17
02/22/19
16:17
Technical Analysis
NASDAQ market internals summary »

Volume was above average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EFC

Ellington Financial

$16.97

-0.01 (-0.06%)

16:16
02/22/19
02/22
16:16
02/22/19
16:16
Hot Stocks
Ellington Financial to convert to a Delaware corporation »

Ellington Financial…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

16:16
02/22/19
02/22
16:16
02/22/19
16:16
Technical Analysis
NYSE market internals summary »

Volume was average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ENLC

EnLink Midstream

$11.38

0.08 (0.71%)

16:14
02/22/19
02/22
16:14
02/22/19
16:14
Syndicate
Breaking Syndicate news story on EnLink Midstream »

EnLink Midstream files…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    May

  • 07

    Aug

  • 06

    Nov

KHC

Kraft Heinz

$34.97

-13.225 (-27.44%)

, K

Kellogg

$56.72

-1.61 (-2.76%)

16:13
02/22/19
02/22
16:13
02/22/19
16:13
On The Fly
Fly Intel: Wall Street's top stories for Friday »

Stocks opened in positive…

KHC

Kraft Heinz

$34.97

-13.225 (-27.44%)

K

Kellogg

$56.72

-1.61 (-2.76%)

STMP

Stamps.com

$83.32

-114.76 (-57.94%)

INTC

Intel

$52.43

1.03 (2.00%)

ZG

Zillow

$43.65

8.58 (24.47%)

Z

Zillow

$44.23

9.2 (26.26%)

W

Wayfair

$150.01

32.87 (28.06%)

ROKU

Roku

$64.85

13.38 (26.00%)

DPLO

Diplomat Pharmacy

$5.87

-7.59 (-56.39%)

CASA

Casa Systems

$10.29

-1.67 (-13.96%)

DBX

Dropbox

$23.49

-2.09 (-8.17%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

  • 22

    Feb

  • 25

    Feb

  • 25

    Feb

  • 25

    Feb

  • 27

    Feb

  • 28

    Feb

  • 03

    Mar

  • 05

    Mar

  • 06

    Mar

  • 07

    Mar

  • 11

    Mar

  • 11

    Mar

  • 12

    Mar

  • 13

    Mar

  • 25

    Mar

  • 25

    Mar

  • 26

    Mar

SVA

Sinovac Biotech

$6.55

0.08 (1.24%)

16:11
02/22/19
02/22
16:11
02/22/19
16:11
Hot Stocks
Sinovac Biotech trading halted by the Nasdaq »

The Nasdaq Stock Market…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DHIL

Diamond Hill Investment Group Inc

$145.50

-7.6 (-4.96%)

16:10
02/22/19
02/22
16:10
02/22/19
16:10
Hot Stocks
Diamond Hill Investment chairman Ric Dillon to retire »

The board of directors of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NEM

Newmont Mining

$36.42

1.03 (2.91%)

, GG

Goldcorp

$11.11

-0.4 (-3.48%)

16:08
02/22/19
02/22
16:08
02/22/19
16:08
Hot Stocks
Newmont Mining, Goldcorp obtain interim order for plan of arrangement »

Newmont Mining (NEM) and…

NEM

Newmont Mining

$36.42

1.03 (2.91%)

GG

Goldcorp

$11.11

-0.4 (-3.48%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HL

Hecla Mining

$2.59

-0.145 (-5.31%)

16:07
02/22/19
02/22
16:07
02/22/19
16:07
Syndicate
Breaking Syndicate news story on Hecla Mining »

Hecla Mining files…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DIOD

Diodes

$41.40

0.39 (0.95%)

, TXN

Texas Instruments

$107.20

0.59 (0.55%)

16:07
02/22/19
02/22
16:07
02/22/19
16:07
Hot Stocks
Diodes names Brett Whitmire as CFO, effective March 1 »

Diodes (DIOD) announced…

DIOD

Diodes

$41.40

0.39 (0.95%)

TXN

Texas Instruments

$107.20

0.59 (0.55%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Feb

NCR

NCR Corp.

$28.90

0.58 (2.05%)

16:06
02/22/19
02/22
16:06
02/22/19
16:06
Hot Stocks
NCR acquires reseller BEC, terms not disclosed »

NCR Corporation announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Feb

TAHO

Tahoe Resources

$3.67

(0.00%)

16:00
02/22/19
02/22
16:00
02/22/19
16:00
Hot Stocks
Breaking Hot Stocks news story on Tahoe Resources »

Tahoe Resources trading…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPY

SPDR S&P 500 ETF Trust

$278.71

1.28 (0.46%)

, SPX

S&P 500

$0.00

(0.00%)

15:57
02/22/19
02/22
15:57
02/22/19
15:57
Periodicals
Special Counsel Mueller will not release his report next week, NBC reports »

Contrary to press…

SPY

SPDR S&P 500 ETF Trust

$278.71

1.28 (0.46%)

SPX

S&P 500

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AAPL

Apple

$172.39

1.27 (0.74%)

15:55
02/22/19
02/22
15:55
02/22/19
15:55
Periodicals
Apple to shutter stores in Eastern District of Texas, MacRumors reports »

Apple intends to shutter…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Mar

  • 01

    Mar

DPLO

Diplomat Pharmacy

$5.67

-7.79 (-57.88%)

15:54
02/22/19
02/22
15:54
02/22/19
15:54
Downgrade
Diplomat Pharmacy rating change  »

Diplomat Pharmacy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Feb

  • 11

    Mar

  • 12

    Mar

LIN

Linde plc

$173.06

1.65 (0.96%)

, LYB

LyondellBasell

$88.93

0.42 (0.47%)

15:51
02/22/19
02/22
15:51
02/22/19
15:51
Hot Stocks
FTC approves Linde's application for sale of plant to LyondellBasell »

The Federal Trade…

LIN

Linde plc

$173.06

1.65 (0.96%)

LYB

LyondellBasell

$88.93

0.42 (0.47%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    May

MGEE

MGE Energy

$66.40

0.42 (0.64%)

15:50
02/22/19
02/22
15:50
02/22/19
15:50
Earnings
MGE Energy reports Q4 EPS 47c vs. $1.04 last year »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KPTI

Karyopharm

$4.91

-4.05 (-45.20%)

15:50
02/22/19
02/22
15:50
02/22/19
15:50
Options
44% dive in shares motivates interest in KKaryopharm far upside calls »

44% dive in shares…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Feb

  • 28

    Feb

  • 06

    Apr

NESR

National Energy Services

$8.75

0.005 (0.06%)

15:48
02/22/19
02/22
15:48
02/22/19
15:48
Syndicate
Breaking Syndicate news story on National Energy Services »

National Energy Services…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Feb

  • 27

    Feb

  • 28

    Feb

NIO

NIO Inc.

$7.97

0.355 (4.66%)

15:44
02/22/19
02/22
15:44
02/22/19
15:44
Periodicals
CBS teases upcoming 60 Minutes feature on NIO Inc. »

The 60 Minutes report,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Mar

BRK.A

Berkshire Hathaway

$302,770.46

-5154.54 (-1.67%)

, BRK.B

Berkshire Hathaway

$201.90

-3.41 (-1.66%)

15:39
02/22/19
02/22
15:39
02/22/19
15:39
Periodicals
Berkshire Hathaway in advanced talks to sell Applied Underwriters, Reuters says »

Berkshire Hathaway is in…

BRK.A

Berkshire Hathaway

$302,770.46

-5154.54 (-1.67%)

BRK.B

Berkshire Hathaway

$201.90

-3.41 (-1.66%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WTW

WW

$29.34

0.27 (0.93%)

15:35
02/22/19
02/22
15:35
02/22/19
15:35
Options
Weight Watchers put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Feb

  • 06

    Mar

15:35
02/22/19
02/22
15:35
02/22/19
15:35
General news
U.S. Treasury Market Summary »

U.S. Treasury Market…

15:28
02/22/19
02/22
15:28
02/22/19
15:28
Conference/Events
House Financial Services Committee to hold a hearing »

The Committee holds a…

IWM

iShares Trust Russell 2000 Index Fund

$157.79

1 (0.64%)

, RUT

Russell 2000 Index

$0.00

(0.00%)

15:22
02/22/19
02/22
15:22
02/22/19
15:22
Technical Analysis
On The Fly: Weekly technical notes for Russell 2000 »

For the holiday-shortened…

IWM

iShares Trust Russell 2000 Index Fund

$157.79

1 (0.64%)

RUT

Russell 2000 Index

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.